Table 2—

Cost elements for male obstructive sleep apnoea(OSA) patients versus matched controls in the 5 yrs prior to diagnosis

Young adultsMiddle-aged adults
ControlOSAp-value#ControlOSAp-value#
Hospitalisation
 Costs US$144.7±44.6 (0; 0–2832)299.5±115.8 (0; 0–12036)0.7575.0±197.1 (0; 0–18408)886.5±221.3 (0; 0–19116)0.161
 Time days0.4±0.1 (0; 0–8)0.8±0.3 (0; 0–34)0.71.6±0.6 (0; 0–52)2.5±0.6 (0; 0–54)0.161
Emergency department
 Costs US$88.7±12.2 (0; 0–665.3)132.7±16.8 (111.0; 0–887.1)0.02086.2±19.1 (0; 0–1996)126.1±22.6 (0; 0–1996)0.049
 Visits n0.8±0.1 (0; 0–6)1.2±0.2 (1; 0–8)0.0240.8±0.2 (0; 0–18)1.1±0.2 (0; 0–18)0.046
Consultation
 Costs US$95.1±10.5 (39.3; 0–472)165.4±14.0 (118; 0–787)<0.0001114.0±14.2 (79; 0–904)285.4±25.3 (197; 0–1967)<0.0001
 Visits n2.4±0.3 (1; 0–12)4.2±0.4 (3; 0–20)<0.00012.9±0.4 (2; 0–23)7.3±0.6 (5; 0–50)<0.0001
Drugs
 Costs US$57.1±10.1 (17; 0–815)165.1±45.4 (37; 0–3322)0.056120.3±24.6 (38; 0–2347)400±68 (158; 0–5126)<0.001
Total costs US$386±55 (162; 0–3030)763±137 (303; 3–12825)0.004895.3±218.2 (236; 0–19305)1698±282.2 (559; 0–24196)0.002
  • Data are presented as mean±sem (median; range) total costs and healthcare utilisation per patient during the 5 yrs prior to OSA diagnosis. #: Wilcoxon test; : p<0.0001 versus middle-aged OSA patients (Mann–Whitney U-test).